US Archives - Page 84 of 157 - European Medical Journal

Dermatology Trials Face a Reckoning on Race and Ethnicity

In dermatology research, the use of race and ethnicity as population descriptors has come under increasing scrutiny, with experts questioning whether these broad categories obscure more than they reveal about human health.

What Drives Survival in HER2+ Breast Cancer?

In a real-world study examining neoadjuvant chemotherapy for human epidermal growth factor receptor 2-positive (HER2+) breast cancer, researchers have identified key predictors of treatment response and long-term survival, providing critical insights for oncologists managing this aggressive disease.

New MRI Measures Offer Clues to Preclinical Alzheimer’s

MRI continues to play a pivotal role in the early detection of Alzheimer’s disease, and new research suggests that using distance measures from MRI data may outperform traditional volumetric assessments in predicting cognitive decline.

Managing Elevated CRP in Sleep Apnea: New Insights

Severe obstructive sleep apnea (OSA) is independently associated with elevated C-reactive protein (CRP) levels, a key marker of systemic inflammation and cardiovascular risk, according to new research analyzing over 2,400 patients.

FMT at Home Cuts CDI Hospitalization Time

Clostridioides difficile infection (CDI) remains a pressing challenge in older adults, particularly those with comorbidities, leading to significant mortality and healthcare costs.

Multimorbidity in Systemic Sclerosis: Hidden Driver of Poor Outcomes

Multimorbidity, the presence of multiple co-existing health conditions, has emerged as a critical factor influencing survival and physical function in patients with systemic sclerosis (SSc), according to a large cohort study of 2,000 participants.

Emerging Guidelines: Photobiomodulation in Focus

Healthcare professionals treating conditions such as peripheral neuropathy, wound ulcers, or radiation dermatitis now have fresh, evidence-based guidance on the use of photobiomodulation (PBM) therapy.

What Physicians Need to Know Before Recommending TORS

In a significant update for head and neck oncology care, new clinical insights into transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPC) aim to guide U.S. physicians in tailoring treatment plans through a multidisciplinary lens.

Lewy Body Dementia Understudied in Latin America

Lewy body dementia (LBD), a complex neurodegenerative disorder, remains severely understudied in Latin America, according to a new scoping review analyzing the regional research landscape across major medical databases.

Imaging Reveals Hidden Risks in High-Risk cSCC Cases

Radiologic imaging in high-risk cutaneous squamous cell carcinoma (cSCC) has proven more valuable than previously recognized, uncovering unexpected findings in nearly half of patients and prompting significant changes in treatment, according to a major retrospective study.